Enveric Biosciences Inc.

NASDAQ: ENVB · Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.09
0.98%
After-hours: Aug 15, 2025, 07:16 PM EDT

Enveric Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.3M -9.57M -9.86M -10.59M -15.07M -17.29M -22.53M -22.19M -18.62M -18.47M -51.9M -52.13M -50.25M -48.98M -9.08M -7.43M -8.19M
Depreciation & Amortization
165.82K 209.05K 211.25K 350.71K 380.3K 408.23K 413.97K 439.23K 444.81K 435.2K 542.03K 594.63K 648.69K 681.61K -1.04M -661.96K -302.11K
Stock-Based Compensation
1.4M 1.56M 1.46M 1.46M 1.97M 2.15M 2.31M 2.59M 2.38M 2.62M 9.86M 9.7M 9.77M 12.6M 6.76M 6.29M 5.55M
Other Working Capital
1.17M 411.39K 735.7K -1.11M 746.01K 851.59K 480.31K 383.19K -507.74K -481.35K -993.44K -741.79K -384.99K 176.12K 381.88K -454.08K -744.91K
Other Non-Cash Items
522.09K 820.56K 2.51M 5.11M 5.72M 5.24M 7M 1.09M -1.42M -1.51M 31.92M 34.29M 33.75M 34.32M -2.06M -1.14M 1.47M
Deferred Income Tax
n/a n/a -1.07M -4.43M -4.43M -4.43M -3.36M n/a n/a n/a -7.45M -7.45M -7.45M -11.27M -3.8M -3.84M -3.83M
Change in Working Capital
133.65K -423.24K -1.09M -1.55M 190.85K -174.75K 357.87K 454.69K -518.85K -217.66K -716.92K -407.02K 689.26K 1.19M 1.82M 573.13K 543.92K
Operating Cash Flow
-7.52M -7.73M -8.17M -9.98M -11.56M -14.09M -15.81M -17.62M -17.73M -17.15M -17.75M -15.41M -12.84M -11.46M -7.42M -6.21M -4.76M
Capital Expenditures
n/a n/a 15.00 10.00 -11 -5.18K -11.39K -29.95K -83.83K -584.16K -767.69K -749.12K -695.23K -864.72K -628.86K -635.03K -631.63K
Cash Acquisitions
n/a n/a -53 -25 16.85K 16.85K 16.9K 16.87K 958.04K 958.04K 958.04K 4.01M 3.06M 3.06M 3.06M n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -0.05 -0.02 16.85 16.85 -584.15K -584.15K -1.54M -1.54M -958.04K 2.1M 3.06M 3.05M 3.01M -44.82K -44.82K
Investing Cash Flow
n/a n/a -38 -18 16.84K 11.67K 5.51K -13.08K -83.83K -584.16K -767.69K 2.31M 2.36M 2.19M 2.38M -679.17K -675.77K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
1.08M 1.08M 1.05M 1.05M n/a n/a -1.05M -1.05M n/a n/a n/a -0.01 -0.01 -0.01 -0.01 n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.84M 4.3M 2.33M 2.22M 2.24M -291.08K -105K n/a 958.04K 958.04K 958.04K 958.03K 17.93K 3.29M 2.5M 4.03M 5.4M
Financial Cash Flow
5.46M 7.67M 7.02M 6.4M 5.32M -1.34M -1.16M 6.77M 8.78M 18.18M 18.18M 10.36M 9.42M 24.9M 24.9M 24.9M 24.89M
Net Cash Flow
-2.06M -46.95K -1.15M -3.58M -6.21M -15.44M -16.93M -10.93M -9.13M 367.88K -247.42K -2.61M -962.62K 15.78M 18.61M 18.53M 21.39M
Free Cash Flow
-7.52M -7.73M -8.17M -9.98M -11.56M -14.1M -15.82M -17.65M -17.82M -17.73M -18.52M -16.16M -13.54M -12.32M -8.05M -6.84M -5.39M